RxSight, Inc. RXST
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -65.29% | -2.64% | -93.94% | -54.13% | -54.88% |
| Total Depreciation and Amortization | 8.78% | 28.74% | 6.24% | 79.54% | -25.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.00% | -8.00% | 28.66% | 39.70% | 51.47% |
| Change in Net Operating Assets | 2,928.88% | -440.47% | 67.91% | 116.59% | -6.48% |
| Cash from Operations | 3,909.27% | -117.96% | -23.31% | 73.80% | -282.62% |
| Capital Expenditure | -102.07% | -27.26% | -32.00% | -34.24% | 47.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 208.27% | -59.18% | -55.17% | -491.19% | -3.26% |
| Cash from Investing | 188.25% | -68.25% | -57.57% | -828.33% | 2.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 63.16% | -133.33% | 46.15% | 175.00% | -72.73% |
| Issuance of Common Stock | 73.28% | -67.65% | -79.31% | -64.66% | -96.58% |
| Repurchase of Common Stock | 96.11% | -- | 66.64% | -- | 75.64% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 136.79% | -67.94% | 54.29% | -64.28% | -160.36% |
| Foreign Exchange rate Adjustments | 500.00% | -78.57% | -50.00% | -25.00% | -128.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 597.67% | -134.16% | -121.04% | -40,445.83% | -38.81% |